PRESCRIBING · PART D · 2024
Total Rx claims
180
Beneficiaries
—
Total drug cost
$990K
Distinct drugs
11
Brand share
58.9%
Top prescribed drugs
Lenvatinib Mesylate33 claims
Imatinib Mesylate23 claims
Apixaban18 claims
Hydrocodone/Acetaminophen17 claims
Diphenoxylate Hcl/Atropine14 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CROSS-REFERENCE